Pia Kivisäkk

11.6k total citations · 2 hit papers
117 papers, 7.6k citations indexed

About

Pia Kivisäkk is a scholar working on Immunology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Pia Kivisäkk has authored 117 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Immunology, 35 papers in Pathology and Forensic Medicine and 25 papers in Neurology. Recurrent topics in Pia Kivisäkk's work include Multiple Sclerosis Research Studies (35 papers), Immunotherapy and Immune Responses (27 papers) and Neuroinflammation and Neurodegeneration Mechanisms (20 papers). Pia Kivisäkk is often cited by papers focused on Multiple Sclerosis Research Studies (35 papers), Immunotherapy and Immune Responses (27 papers) and Neuroinflammation and Neurodegeneration Mechanisms (20 papers). Pia Kivisäkk collaborates with scholars based in United States, Sweden and United Kingdom. Pia Kivisäkk's co-authors include Richard M. Ransohoff, Grahame J. Kidd, Hans Link, Darius Matusevičius, Nikolaos Kostulas, Howard L. Weiner, S. Fredrikson, Corinna Trebst, Samia J. Khoury and Volkan Özenci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Pia Kivisäkk

111 papers receiving 7.5k citations

Hit Papers

Three or more routes for leukocyte migration into the cen... 1999 2026 2008 2017 2003 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pia Kivisäkk United States 42 3.5k 2.1k 2.1k 1.8k 1.5k 117 7.6k
Abdolmohamad Rostami United States 51 5.5k 1.6× 1.3k 0.6× 2.0k 0.9× 1.9k 1.1× 1.6k 1.0× 185 9.4k
Manuel A. Friese Germany 42 3.8k 1.1× 1.6k 0.8× 2.6k 1.2× 2.5k 1.4× 1.3k 0.8× 120 9.2k
Jia Newcombe United Kingdom 56 3.2k 0.9× 2.4k 1.1× 2.9k 1.4× 2.7k 1.5× 1.3k 0.8× 102 9.6k
Doron Merkler Switzerland 51 3.9k 1.1× 3.0k 1.4× 2.2k 1.0× 2.4k 1.3× 1.2k 0.8× 152 10.1k
Mohsen Khademi Sweden 47 2.5k 0.7× 901 0.4× 2.6k 1.2× 1.7k 0.9× 1.0k 0.7× 130 6.7k
Bruno Gran United Kingdom 47 4.5k 1.3× 1.0k 0.5× 2.2k 1.0× 1.7k 0.9× 1.3k 0.9× 120 7.8k
Guang‐Xian Zhang United States 44 4.2k 1.2× 1.1k 0.5× 1.3k 0.6× 1.8k 1.0× 1.1k 0.7× 157 7.2k
Luca Battistini Italy 60 5.0k 1.5× 1.2k 0.6× 1.5k 0.7× 3.4k 1.9× 1.5k 1.0× 157 11.4k
Halina Offner United States 62 8.8k 2.5× 3.3k 1.5× 2.0k 1.0× 2.4k 1.3× 2.0k 1.3× 316 14.0k
Piet Stinissen Belgium 48 3.5k 1.0× 971 0.5× 1.9k 0.9× 1.4k 0.8× 881 0.6× 162 6.7k

Countries citing papers authored by Pia Kivisäkk

Since Specialization
Citations

This map shows the geographic impact of Pia Kivisäkk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Kivisäkk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Kivisäkk more than expected).

Fields of papers citing papers by Pia Kivisäkk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pia Kivisäkk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Kivisäkk. The network helps show where Pia Kivisäkk may publish in the future.

Co-authorship network of co-authors of Pia Kivisäkk

This figure shows the co-authorship network connecting the top 25 collaborators of Pia Kivisäkk. A scholar is included among the top collaborators of Pia Kivisäkk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pia Kivisäkk. Pia Kivisäkk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chao‐Yi, Hiroko H. Dodge, Shannon Leslie, et al.. (2025). Unbiased CSF Proteomics in Patients With Idiopathic Normal Pressure Hydrocephalus to Identify Molecular Signatures and Candidate Biomarkers. Neurology. 104(5). e213375–e213375. 1 indexed citations
2.
Wu, Chao‐Yi, Chen Liu, Jennifer R. Gatchel, et al.. (2025). Combined use of plasma p‐tau217, NfL, and GFAP predicts domain‐specific cognitive decline in cognitively unimpaired and MCI individuals. Alzheimer s & Dementia. 21(12). e70934–e70934.
3.
Ye, Rong, Pia Kivisäkk, Michael J Properzi, et al.. (2025). Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body Disease. Movement Disorders. 40(9). 1930–1939.
4.
Wu, Chao‐Yi, Chen Liu, Alison J. McManus, et al.. (2025). Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(1). e70023–e70023. 4 indexed citations
5.
Lin, Jonathan B., Stephanie A. Schultz, Yixi Xue, et al.. (2025). Evaluation of Serum and Aqueous Humor Neurofilament Light Chain as Markers of Neurodegeneration in Glaucoma. Translational Vision Science & Technology. 14(2). 24–24. 2 indexed citations
6.
Trombetta, Bianca A., Chao‐Yi Wu, Hiroko H. Dodge, et al.. (2024). Cerebrospinal fluid biomarker profiling of diverse pathophysiological domains in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(1). e12440–e12440. 5 indexed citations
7.
Vallabh, Sonia M., Shona W. Allen, Pia Kivisäkk, et al.. (2024). Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion. Neurology. 103(2). e209506–e209506. 3 indexed citations
8.
Fonseca, Luciana Mascarenhas, Michal Schnaider Beeri, Zoë Hawks, et al.. (2024). ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(4). e70029–e70029. 1 indexed citations
9.
Lee, Hyowon, Waijiao Cai, Xiaochang Xue, et al.. (2024). Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers. npj Parkinson s Disease. 10(1). 152–152. 12 indexed citations
10.
Arnold, Steven E., Suzanne Hendrix, Jessie Nicodemus‐Johnson, et al.. (2024). Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12487–e12487. 5 indexed citations
11.
Imitola, Jaime, Ethan W. Hollingsworth, Marta Olah, et al.. (2023). Stat1 is an inducible transcriptional repressor of neural stem cells self-renewal program during neuroinflammation. Frontiers in Cellular Neuroscience. 17. 1156802–1156802. 11 indexed citations
12.
Saffari, Afshin, M. L. ZIEGLER, Catherine Jordan, et al.. (2023). Plasma Neurofilament Light Chain Is Elevated in Adaptor Protein Complex 4‐Related Hereditary Spastic Paraplegia. Movement Disorders. 38(9). 1742–1750. 6 indexed citations
13.
Fonseca, Luciana Mascarenhas, Pia Kivisäkk, Zoë Hawks, et al.. (2023). Plasma Alzheimer’s disease biomarkers and intraindividual cognitive variability measured by ecological momentary assessment in adults with type 1 diabetes. Alzheimer s & Dementia. 19(S15). 1 indexed citations
14.
Kautz, Tiffany F., Pia Kivisäkk, Claudia L. Satizábal, et al.. (2023). The effect of fasting status on Alzheimer’s disease plasma biomarkers AB40, AB42, GFAP, NfL, CD‐14, and YKL‐40. Alzheimer s & Dementia. 19(S15). 3 indexed citations
15.
Kivisäkk, Pia, et al.. (2022). A Nuclear Magnetic Resonance Spectroscopy Method in Characterization of Blood Metabolomics for Alzheimer’s Disease. Metabolites. 12(2). 181–181. 9 indexed citations
16.
Roostaei, Tina, Hans‐Ulrich Klein, Yiyi Ma, et al.. (2021). Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome. Nature Communications. 12(1). 12 indexed citations
17.
Sádaba, María C., Veit Rothhammer, Úrsula Muñoz, et al.. (2020). Serum antibodies to phosphatidylcholine in MS. Neurology Neuroimmunology & Neuroinflammation. 7(4). 17 indexed citations
18.
Elyaman, Wassim, Elizabeth M. Bradshaw, Yue Wang, et al.. (2007). Jagged1 and Delta1 Differentially Regulate the Outcome of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 179(9). 5990–5998. 90 indexed citations
19.
Trebst, Corinna, Susan M. Staugaitis, Pia Kivisäkk, et al.. (2003). CC Chemokine Receptor 8 in the Central Nervous System Is Associated with Phagocytic Macrophages. American Journal Of Pathology. 162(2). 427–438. 43 indexed citations
20.
Xiao, Bao‐Guo, Alyaa Mousa, Pia Kivisäkk, & Åke Seiger. (1998). Induction of β-family chemokines mRNA in human embryonic astrocytes by inflammatory cytokines. Journal of Neurocytology. 27(8). 575–580. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026